Inhibition of human thrombin by the constituents of licorice: inhibition kinetics and mechanistic insights through in vitro and in silico studies | |
Shi, Cheng-Cheng2,3; Chen, Tian-Ran3,4,5; Zhang, Qi-Hua6; Wei, Ling-Hua1; Huang, Chao3; Zhu, Ya-Di3; Liu, Hai-Bin4; Bai, Ya-Kun1; Wang, Fang-Jun7; Guo, Wen-Zhi1 | |
刊名 | RSC ADVANCES |
2020-01-23 | |
卷号 | 10期号:7页码:3626-3635 |
DOI | 10.1039/c9ra09203j |
通讯作者 | Guo, Wen-Zhi(guowz66@163.com) ; Zhang, Li-Rong(zhanglirongzzu@126.com) ; Ge, Guang-Bo(geguangbo@dicp.ac.cn) |
英文摘要 | Thrombin inhibition therapy is a practical strategy to reduce thrombotic and cardiovascular risks via blocking the formation of blood clots. This study aimed to identify naturally occurring thrombin inhibitors from licorice (one of the most popular edible herbs), as well as to investigate their inhibitory mechanisms. Among all tested licorice constituents, licochalcone A was found as the most efficacious agent against human thrombin (IC50 = 7.96 mu M). Inhibition kinetic analyses demonstrated that licochalcone A was a mixed inhibitor against thrombin-mediated Z-Gly-Gly-Arg-AMC acetate hydrolysis, with a K-i value of 12.23 mu M. Furthermore, mass spectrometry-based chemoproteomic assays and molecular docking simulations revealed that licochalcone A could bind to human thrombin at both exosite I and the catalytic site. In summary, our findings demonstrated that the chalcones isolated from licorice were a new class of direct thrombin inhibitors, also suggesting that licochalcone A was a promising lead compound for developing novel anti-thrombotic agents. |
资助项目 | National Key Research and Development Program of China[2017YFC1700200] ; National Key Research and Development Program of China[2017YFC1702000] ; National Natural Science Foundation of China[81973286] ; National Natural Science Foundation of China[81803489] ; National Natural Science Foundation of China[U1604282] ; National Natural Science Foundation of China[81973393] ; National Natural Science Foundation of China[81922070] ; National Natural Science Foundation of China[81773687] ; Program of Shanghai Academic/Technology Research Leader[18XD1403600] ; Basic and Frontier Technology Research Program of Henan Science and Technology Commission Foundation[142300410039] ; TaiShan Industrial Experts Program[tscy20180234] |
WOS关键词 | TRADITIONAL CHINESE MEDICINE ; BIOACTIVE CONSTITUENTS ; BIOLOGICAL EVALUATION ; CHALCONE DERIVATIVES ; DESIGN ; DISCOVERY ; POTENT ; LICOCHALCONE ; FLAVONOIDS ; ACID |
WOS研究方向 | Chemistry |
语种 | 英语 |
出版者 | ROYAL SOC CHEMISTRY |
WOS记录号 | WOS:000509900800001 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/281654] |
专题 | 中国科学院上海药物研究所 |
通讯作者 | Guo, Wen-Zhi; Zhang, Li-Rong; Ge, Guang-Bo |
作者单位 | 1.Zhengzhou Univ, Henan Key Lab Digest Organ Transplantat, Dept Hepatobiliary & Pancreat Surg, Affiliated Hosp 1, Zhengzhou, Peoples R China 2.Zhengzhou Univ, Sch Basic Med Sci, Dept Pharmacol, Zhengzhou, Henan, Peoples R China 3.Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Med Res, Shanghai, Peoples R China 4.Dong E E Jiao Co Ltd, Natl Engn Res Ctr Gelatin Based Tradit Chinese Me, Shandong, Peoples R China 5.Zhengzhou Univ, Affiliated Hosp 5, Dept Gastrointestinal Surg, Zhengzhou, Peoples R China 6.Chinese Acad Sci, CAS Key Lab Receptor Res, Drug Discovery & Design Ctr, Shanghai Inst Mat Med, Shanghai, Peoples R China 7.Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian 116023, Peoples R China |
推荐引用方式 GB/T 7714 | Shi, Cheng-Cheng,Chen, Tian-Ran,Zhang, Qi-Hua,et al. Inhibition of human thrombin by the constituents of licorice: inhibition kinetics and mechanistic insights through in vitro and in silico studies[J]. RSC ADVANCES,2020,10(7):3626-3635. |
APA | Shi, Cheng-Cheng.,Chen, Tian-Ran.,Zhang, Qi-Hua.,Wei, Ling-Hua.,Huang, Chao.,...&Ge, Guang-Bo.(2020).Inhibition of human thrombin by the constituents of licorice: inhibition kinetics and mechanistic insights through in vitro and in silico studies.RSC ADVANCES,10(7),3626-3635. |
MLA | Shi, Cheng-Cheng,et al."Inhibition of human thrombin by the constituents of licorice: inhibition kinetics and mechanistic insights through in vitro and in silico studies".RSC ADVANCES 10.7(2020):3626-3635. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论